Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Eton Pharmaceuticals develops and commercializes treatments for rare diseases, offering products across endocrinology and metabolic disorders. Its portfolio includes FDA-approved drugs like INCRELEX, ALKINDI SPRINKLE, and GALZIN, with additional candidates in late-stage development. The company leverages regulatory expertise, proprietary technology, and established sales channels to serve niche patient populations worldwide. Its business model focuses on innovation, strategic acquisitions, and efficient manufacturing partnerships.
This description was generated via AI from an annual report. Updated about 1 year ago.